Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease

Background Fabry disease is a lysosomal X-linked enzyme deficiency of α-galactosidase A associated with an increased mortality and morbidity due to renal failure, cardiac disease and early onset stroke.